Alta's $167.5M-$177.5M EBITDA Target Looks Solid. The $100M Cash Target Is the Real Test.

Alta's Q2 rebound supports the EBITDA guide, but cash conversion is the harder test

Alta has narrowed its 2026 adjusted EBITDA guidance to $172.5 million at the midpoint, which maps to a $167.5 million-$177.5 million range. That looks supportable because Q2 already delivered $48.6 million of adjusted EBITDA.

The bigger challenge sits further downstream. Investors are not only being asked to back an EBITDA recovery; they are also being asked to believe Alta can still target roughly $100 million in free cash flow while working capital and timing risks remain in focus.

Why the EBITDA rebound captured attention

Q2 gave the market a clear recovery story. Revenue rose to $475.5 million, up about $65 million sequentially from Q1, and adjusted EBITDA jumped from $28.1 million to $48.6 million. That is enough to make investors optimistic that margins and operating leverage are stabilizing.

There is some justification for that read. But Alta still missed revenue expectations, reported a non-GAAP loss of $0.04 per share, and showed a free cash flow margin of 0.5% in Q2. So the key question is not whether the quarter improved. It is whether that improvement is translating into cash at a sustainable level.

Why bulls think the 2026 EBITDA range is achievable

The weak Q1 looked temporary, not structural

Management attributed the softer first quarter to harsh winter conditions and a pull-forward of equipment purchases into Q4 2025, not to a fundamental collapse in demand. If those were mainly timing and weather blocks, then the Q2 rebound looks less like luck and more like normalization.

That is why the next quarter mattered. Revenue improved by $65.0 million sequentially, and adjusted EBITDA climbed from $28.1 million to $48.6 million. Bulls read that as evidence that fixed costs are being spread across more activity and that profit can improve faster than revenue as utilization recovers.

Material Handling backlog gives the recovery more substance

The clearest support for the bullish case sits in Material Handling. Management said backlog reached about $143 million, and earlier commentary noted that March was the strongest booking month since June 2023. That does not guarantee results, but it does point to more committed demand that can help support equipment and service revenue later in the year.

Bulls also have a cyclical piece to their argument. Management had already flagged early signs of a cyclical inflection in Material Handling, while Construction demand was being supported by fully funded state and federal infrastructure spending. In that framing, Q1 was distorted, Q2 showed the turn, and backlog provides a bridge into the second half.

Why the $100 million free cash flow target still needs proving

Q2 adjusted EBITDA came in at $48.6 million, above expectations. But free cash flow margin fell to 0.5% from 2.5% a year earlier, and the stock finished the reporting window near the upper half of its 52-week range. That combination suggests the market is leaning into the earnings rebound before the cash profile has fully re-established itself.

Earnings can recover before cash does

When a weak quarter is driven by harsh winter conditions and a pull-forward of equipment purchases into Q4 2025, EBITDA and cash flow do not have to recover on the same timetable. Margins, pricing, and mix can improve before working-capital timing, fleet discipline, and collection patterns settle.

That is why management's cash target matters so much. Even after the Q2 margin pressure, Alta is still aiming for $100 million-$110 million of free cash flow. Bulls think that is achievable because Q2 revenue reached $475.5 million and adjusted EBITDA margin expanded to 10.2%. If cash conversion improves from this low base while demand holds, the story moves closer to a durable recovery.

What investors should watch next

The near-term debate is straightforward:

• EBITDA vs. cash conversion: EBITDA is the easier target to defend. Free cash flow is the harder test of whether the recovery is sticky.
• Backlog into bookings: About $143 million of backlog and March the strongest booking month since June 2023 support the recovery case, but investors need to see that activity convert into sustained sales.
• No repeat of the same disruptions: The target becomes harder to defend if weather-related disruption or another pull-forward of equipment sales distorts the year again.

The EBITDA range looks plausible given the Q2 rebound. The free cash flow target is the real validation point, because that is where operating improvement has to become financial durability.